The nForming allergy treatment market smart books contain historical and forecasted data about revenue, sales volume, prices, and more for each covered segment at the regional and country level. The smart book also has information about key suppliers and their share of the allergy treatment market. The qualitative aspects include detailed allergy treatment market growth drivers, top opportunities, and major challenges.

Allergy Treatment Market Trends

Several trends have emerged in the allergy therapy market in recent years. The rising frequency of allergies has contributed to the expansion of the allergy immunotherapy market. Allergies afflict up to 30% of the global population, according to the World Allergy Organization. Furthermore, the allergy immunotherapy industry is seeing an increase in demand for personalized treatments. As a result, customized allergy immunotherapy treatments that are tailored to the specific needs of individual patients have been developed.

Furthermore, as an alternative to standard allergy shots, sublingual immunotherapy has grown in popularity in recent years. Sublingual immunotherapy involves putting an allergen extraction underneath the tongue, which is less intrusive and more convenient than allergy injections. Overall, these developments are helping to drive the expansion and growth of the allergy treatment market, thereby increasing the quality of life for allergy sufferers worldwide.

Allergy Treatment Market Drivers

The number of food allergy cases is rapidly increasing.

According to recent data, between 1.1 and 10.8% of the world’s population has an allergy to foods, and the prevalence of food allergies appears to be rising. In countries such as the U.S., around 32 million individuals report having a reaction to foods, and approximately 200,000 people require emergency medical care each year due to food allergies. Food allergies affect 17 million people in Europe alone.

Food allergy cases have increased by up to 50% in the last decade, with hospitalizations caused by anaphylaxis increasing by 700%. There are several possibilities proposed as probable explanations for the rise in allergy disorders. As a result, identifying the specific cause and preventing it completely can be difficult for individuals and kids who have hectic schedules. As a result, a patient must rely on allergy therapies to protect against serious side effects.

As a result, there will be a tremendous drive to embrace and subscribe to food allergy treatment items. This is projected to propel the allergy treatment market through 2030.

In the United States, allergy seasons are becoming more severe.

Asthma and allergy attacks are relatively frequent chronic illnesses that affect kids as well as adults in the United States. Allergies affect up to 50 million individuals each year, according to the Allergy Foundation of America.

Furthermore, as a result of climate change, allergy seasons are getting progressively worse and lasting longer. Warmer temperatures, according to studies, are generating more intense and longer pollen seasons. Experts expect that if these changes continue, allergy seasons in places where they are generally short or less strong may extend. For example, in the United States, spring allergy season normally begins in the latter half of March and lasts until early June. However, in certain areas, the spring allergy period has recently increased on both the front and back ends, beginning in late February and extending until late June.

More drivers can be found in the Smart Book.

Revolutionary allergy immunotherapy segment

Continuous R&D efforts have resulted in the creation of enhanced sublingual allergy immunotherapy (SLIT) formulations that include standardized allergen extracts and innovative delivery mechanisms. SLIT encompasses specific remedies created for an individual, particularly for allergies to dust mites, grass, birch, cats, and others. When developing an AIT treatment plan, allergy doctors frequently employ these preparations.

The possibility of including many allergens that are not included in the presently FDA-approved tablet has enhanced the application of sublingual immunotherapy drops. The present disadvantage of this treatment is that it is not FDA-approved, therefore it is not covered by most health insurance plans, Medicare, or Medicaid.

However, numerous organizations throughout the world are conducting studies to provide solid evidence for the effectiveness of SLIT. The positive outcomes of such initiatives may increase the overall size of the global allergy treatment market.

More opportunities can be found in the Smart Book.

Allergy Treatment Market’s Key Suppliers

• Merck KGaA (Allergopharma)
• GlaxoSmithKline plc
• Hoffmann-La Roche Ltd. (Genentech Inc.)
• Johnson & Johnson
• Allergy Therapeutics plc
• AALK-Abello A/S
• Sanofi SA
• Stallergenes Greer plc
• Allergan Plc.
• Merck & Co. Inc.
• AstraZeneca
• Pfizer Inc.

Allergy Treatment Market Segmentation: